Kedrion Biopharma
Ahmad Harastani is an experienced executive in the biopharmaceutical industry, currently serving as Vice President of Commercial Operations for Asia and Russia at Kedrion Biopharma since April 2023. Prior to this role, Ahmad Harastani held multiple leadership positions at Bio Products Laboratory Limited from March 2016 to May 2023, including Vice President for AMEA & Intermediates and Senior Director for the Asia, Middle East, and Africa region. Ahmad Harastani also worked at Biotest AG between October 2009 and February 2016, where professional experience encompassed roles such as Regional Director for the Middle East/Africa and International Sales Manager for the Asia Pacific. Academically, Ahmad Harastani earned an M.B.A. in General Management from the International School of Management in Germany and a Bachelor of Applied Science in Pharmacy from Damascus University.
This person is not in any teams
This person is not in any offices
Kedrion Biopharma
19 followers
Kedrion Biopharma is a biopharmaceutical company that collects and fractionates blood plasma to produce and distribute worldwide plasma-derived therapies for use in treating and preventing rare and serious diseases and conditions. In 2022, Kedrion joined forces with BPL (Bio Products Laboratory). Based in the United Kingdom, BPL has over 60 years of experience in the supply of high-quality plasma-derived medicines to treat rare diseases. Kedrion distributes its products in over 100 countries around the world. We have plants in Italy, Hungary, UK and North America, and plasma collection centers in the US and in the Czech Republic. With these figures we are the world’s 5th top player in the field of plasma-derived products. Our goal is to build a diverse and professional workforce, providing job opportunities for talented external candidates as well as internal employees who aim to grow with us. Because our work includes so many interests and skills – from Research to Sales; Plasma Collection to Production – there are abundant possibilities for learning and growth. Kedrion builds bridges: from donors to patients, from plasma to therapies, from challenge to hope.